Search
Patexia Research
Case number 2018-2124

Shire Orphan Therapies v. Fresenius Kabi USA > Documents

Date Field Doc. No.Description (Pages)
Nov 16, 2018 41 ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [40] filed by Appellees Sanofi-Aventis Deutschland GmbH, Shire Orphan Therapies LLC and Appellant Fresenius Kabi USA, LLC; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [565726] [JAB] [Entered: 11/16/2018 09:59 AM] (2)
Nov 15, 2018 40 MOTION of Appellant Fresenius Kabi USA, LLC and Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 11/15/2018 by email. [565619] [18-2124] [Stephen Schreiner] [Entered: 11/15/2018 05:57 PM] (3)
Oct 22, 2018 39 NOTICE OF ORAL ARGUMENT. Panel: 1812D. Case scheduled Dec 03, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 11/15/2018. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [559078] [JAB] [Entered: 10/22/2018 11:38 AM] (2)
Oct 19, 2018 38 Notice from Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC regarding conflicts with oral argument (Scheduling conflicts for the December, January, and February court weeks on December 6 and 7, January 9 and 10, and February 4 and 5.). Service: 10/19/2018 by email. [558720] [18-2124] [Edgar Haug] [Entered: 10/19/2018 11:15 AM] (2)
Oct 15, 2018 37 6 paper copies of the Joint Appendix Brief (Vol. I - II) [35] received from Appellant Fresenius Kabi USA, LLC. [557400] [CJF] [Entered: 10/16/2018 09:19 AM] (0)
Oct 12, 2018 36 Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [DEC, JAN, FEB], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 10/19/2018. [556785] [MJL] [Entered: 10/12/2018 03:58 PM] (0)
Oct 12, 2018 34 Notice from Appellant Fresenius Kabi USA, LLC regarding conflicts with oral argument (12/04/2018). Service: 10/12/2018 by email. [556704] [18-2124] [William Jay] [Entered: 10/12/2018 01:28 PM] (2)
Oct 10, 2018 33 6 CD-ROMs of the Opening Response Brief [23] received from Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. [555990] [CJF] [Entered: 10/10/2018 12:13 PM] (0)
Oct 9, 2018 35 APPENDIX FILED for Fresenius Kabi USA, LLC [28]. Number of Pages: 615. Service: 10/09/2018 by email. The paper copies of the appendix should be received by the court on or before 10/19/2018. [556731] [MJL] [Entered: 10/12/2018 02:24 PM] (615)
Oct 9, 2018 32 Notice of intent to file corresponding briefs on CD-ROM for Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Service: 10/09/2018 by email. [555697] [18-2124] [Laura Chubb] [Entered: 10/09/2018 03:43 PM] (3)
Oct 9, 2018 31 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Service: 10/09/2018 by email. [555582] [18-2124] [Laura Chubb] [Entered: 10/09/2018 12:39 PM] (3)
Oct 9, 2018 30 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Fresenius Kabi USA, LLC. Service: 10/09/2018 by email. [555529] [18-2124] [William Jay] [Entered: 10/09/2018 10:50 AM] (3)
Oct 9, 2018 29 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Fresenius Kabi USA, LLC. Service: 10/09/2018 by email. [555528] [18-2124] [William Jay] [Entered: 10/09/2018 10:49 AM] (2)
Oct 9, 2018 28 TENDERED from Appellant Fresenius Kabi USA, LLC. Title: JOINT APPENDIX. Service: 10/09/2018 by email. [555506] [18-2124] [William Jay] [Entered: 10/09/2018 10:23 AM] (615)
Oct 4, 2018 27 6 paper copies of the Reply Brief [26] received from Appellant Fresenius Kabi USA, LLC. [554958] [CJF] [Entered: 10/04/2018 03:03 PM] (0)
Oct 1, 2018 26 REPLY BRIEF FILED for Appellant Fresenius Kabi USA, LLC [25]. Number of Pages: 30. Service: 10/01/2018 by email. The paper copies of the brief should be received by the court on or before 10/12/2018. Appendix is due 10/09/2018. [554792] [SJ] [Entered: 10/04/2018 11:01 AM] (40)
Oct 1, 2018 25 TENDERED from Appellant Fresenius Kabi USA, LLC. Title: REPLY BRIEF. Service: 10/01/2018 by email. [553891] [18-2124] [William Jay] [Entered: 10/01/2018 05:29 PM] (40)
Sep 25, 2018 24 6 paper copies of the Opening Response Brief [23] received from Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. [552295] [CJF] [Entered: 09/25/2018 09:57 AM] (0)
Sep 18, 2018 23 BRIEF FILED for Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC [22]. Number of Pages: 74. Service: 09/18/2018 by email. The paper copies of the brief should be received by the court on or before 09/28/2018. Appellant Fresenius Kabi USA, LLC reply brief is due 10/02/2018. [551841] [SJ] [Entered: 09/21/2018 04:15 PM] (89)
Sep 18, 2018 22 TENDERED from Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Title: RESPONSE BRIEF. Service: 09/18/2018 by email. [550859] [18-2124] [Edgar Haug] [Entered: 09/18/2018 10:23 PM] (89)
Aug 6, 2018 21 6 paper copies of the Opening Brief [20] received from Appellant Fresenius Kabi USA, LLC. [540917] [CJF] [Entered: 08/06/2018 12:26 PM] (0)
Aug 2, 2018 20 BRIEF FILED for Appellant Fresenius Kabi USA, LLC [19]. Number of Pages: 65. Service: 08/02/2018 by email. The paper copies of the brief should be received by the court on or before 08/10/2018. [540745] [SJ] [Entered: 08/03/2018 03:28 PM] (158)
Aug 2, 2018 19 TENDERED from Appellant Fresenius Kabi USA, LLC. Title: OPENING BRIEF. Service: 08/02/2018 by email. [540530] [18-2124] [William Jay] [Entered: 08/02/2018 05:08 PM] (158)
Jul 17, 2018 18 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [16], attorney entry of appearance Docket No. [15], attorney entry of appearance Docket No. [14], ERROR: use of 'et al.' is discouraged by the court; certain information does not match. CORRECTION: all future filings should list all parties; Ms. Kuzmich's attorney acct. (listing Frommer Lawrence) should be updated to reflect information on EOA. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [536523] [SJ] [Entered: 07/17/2018 01:20 PM] (0)
Jul 16, 2018 17 Notice of intent to file corresponding briefs on CD-ROM for Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Service: 07/16/2018 by email. [536107] [18-2124] [Laura Chubb] [Entered: 07/16/2018 02:16 PM] (3)
Jul 16, 2018 16 Entry of appearance for Laura A. Chubb as of counsel for Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Service: 07/16/2018 by email. [536104] [18-2124] [Laura Chubb] [Entered: 07/16/2018 02:14 PM] (2)
Jul 16, 2018 15 Entry of appearance for Sandra Kuzmich as of counsel for Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Service: 07/16/2018 by email. [536103] [18-2124] [Laura Chubb] [Entered: 07/16/2018 02:12 PM] (2)
Jul 16, 2018 14 Entry of appearance for Edgar H. Haug as principal counsel for Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Service: 07/16/2018 by email. [536101] [18-2124] [Laura Chubb] [Entered: 07/16/2018 02:10 PM] (2)
Jul 16, 2018 13 Certificate of Interest for the Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Service: 07/16/2018 by email. [536098] [18-2124] [Laura Chubb] [Entered: 07/16/2018 02:08 PM] (3)
Jul 16, 2018 12 Docketing Statement for the Appellees Sanofi-Aventis Deutschland GmbH and Shire Orphan Therapies LLC. Service: 07/16/2018 by email. [536095] [18-2124] [Laura Chubb] [Entered: 07/16/2018 02:06 PM] (3)
Jul 10, 2018 11 ORDER filed. The motion [10] is granted to the extent that Fresenius's opening brief is due no later than August 2, 2018 and the appellees' response brief is due no later than September 18, 2018. The case shall be placed on the next available oral argument calendar after briefing is complete. Service: 07/10/2018 by clerk. [534736] [LMS] [Entered: 07/10/2018 10:27 AM] (2)
Jul 5, 2018 10 MOTION of Appellant Fresenius Kabi USA, LLC to expedite. [Consent: partial consent]. Service: 07/05/2018 by email. [533932] [18-2124] [William Jay] [Entered: 07/05/2018 07:20 PM] (11)
Jul 5, 2018 9 Corrected Entry of appearance for Daryl Wiesen as of counsel for Appellant Fresenius Kabi USA, LLC. Service: 07/05/2018 by email. [533930] [18-2124] [William Jay] [Entered: 07/05/2018 06:44 PM] (2)
Jul 5, 2018 8 Entry of appearance for David J. Zimmer as of counsel for Appellant Fresenius Kabi USA, LLC. Service: 07/05/2018 by email. [533929] [18-2124] [William Jay] [Entered: 07/05/2018 06:33 PM] (2)
Jul 5, 2018 7 Entry of appearance for Daryl L. Wiesen as of counsel for Appellant Fresenius Kabi USA, LLC. Service: 07/05/2018 by email. [533928] [18-2124] [William Jay] [Entered: 07/05/2018 06:27 PM] (2)
Jul 5, 2018 6 Entry of appearance for John Coy Stull as of counsel for Appellant Fresenius Kabi USA, LLC. Service: 07/05/2018 by email. [533927] [18-2124] [William Jay] [Entered: 07/05/2018 06:24 PM] (2)
Jul 5, 2018 5 Entry of appearance for William M. Jay as principal counsel for Appellant Fresenius Kabi USA, LLC. Service: 07/05/2018 by email. [533926] [18-2124] [William Jay] [Entered: 07/05/2018 06:22 PM] (2)
Jul 5, 2018 4 Entry of appearance for William G. James as of counsel for Appellant Fresenius Kabi USA, LLC. Service: 07/05/2018 by email. [533925] [18-2124] [William Jay] [Entered: 07/05/2018 06:20 PM] (2)
Jul 5, 2018 3 Docketing Statement for the Appellant Fresenius Kabi USA, LLC. Service: 07/05/2018 by email. [533923] [18-2124] [William Jay] [Entered: 07/05/2018 06:12 PM] (3)
Jul 5, 2018 2 Certificate of Interest for the Appellant Fresenius Kabi USA, LLC. Service: 07/05/2018 by email. [533920] [18-2124] [William Jay] [Entered: 07/05/2018 06:09 PM] (3)
Jul 2, 2018 1 Appeal docketed. Received: 06/27/2018. [533035]Entry of Appearance due 07/16/2018. Certificate of Interest is due on 07/16/2018. Docketing Statement due 07/16/2018. Appellant/Petitioner's brief is due 08/31/2018. [SJ] [Entered: 07/02/2018 10:37 AM] (72)
Menu